{"LNT": {"Ticker": "LNT", "Company": "Alliant Energy", "Sector": "Utilities", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$57 to $56"}, {"Date": "2022-10-20", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-10-03", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$58"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities", "Credit Suisse", "Wolfe Research"], "Price_Target": 57.0}, "AMAT": {"Ticker": "AMAT", "Company": "Applied Materials", "Sector": "Information Technology", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$125"}, {"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-10-21", "Rating": "Upgrade", "Organization": "New Street", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2022-10-17", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Mkt Perform", "Target_Change": ""}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Loop Capital", "New Street", "William Blair", "Summit Insights"], "Price_Target": 125.0}, "BIO": {"Ticker": "BIO", "Company": "Bio-Rad Laboratories", "Sector": "Health Care", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$565"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["RBC Capital Mkts"], "Price_Target": 565.0}, "TECH": {"Ticker": "TECH", "Company": "Bio-Techne", "Sector": "Health Care", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$89"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["RBC Capital Mkts"], "Price_Target": 89.0}, "BKNG": {"Ticker": "BKNG", "Company": "Booking Holdings", "Sector": "Consumer Discretionary", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Wolfe Research"], "Price_Target": 0}, "BWA": {"Ticker": "BWA", "Company": "BorgWarner", "Sector": "Consumer Discretionary", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Upgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral to Outperform", "Target_Change": "$49"}, {"Date": "2022-11-28", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$35 to $45"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Morgan Stanley", "Exane BNP Paribas"], "Price_Target": 47.0}, "CTRA": {"Ticker": "CTRA", "Company": "Coterra", "Sector": "Energy", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Sell", "Target_Change": "$27 to $23"}, {"Date": "2022-11-30", "Rating": "Downgrade", "Organization": "Tudor, Pickering, Holt & Co.", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-11-07", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Underperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-10-25", "Rating": "Resumed", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$40"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$32"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Stifel", "Jefferies", "Wolfe Research", "Tudor, Pickering, Holt & Co.", "Citigroup"], "Price_Target": 31.67}, "D": {"Ticker": "D", "Company": "Dominion Energy", "Sector": "Utilities", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$73 to $64"}, {"Date": "2022-11-17", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$78"}, {"Date": "2022-11-14", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$72 to $69"}, {"Date": "2022-11-09", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$94 to $59"}, {"Date": "2022-11-07", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-11-07", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$83 to $73"}, {"Date": "2022-11-07", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$83 to $76"}, {"Date": "2022-11-07", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$76 to $69"}, {"Date": "2022-10-20", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-10-06", "Rating": "Downgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-10-03", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$82"}], "Score": -1.09, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 11, "Period": "180 days", "Letter_Rating": "D", "Analists": ["KeyBanc Capital Markets", "BofA Securities", "Wolfe Research", "UBS", "Credit Suisse", "Evercore ISI", "JP Morgan", "Seaport Research Partners", "Wells Fargo", "Goldman"], "Price_Target": 71.25}, "EXPE": {"Ticker": "EXPE", "Company": "Expedia Group", "Sector": "Consumer Discretionary", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$85"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Wolfe Research"], "Price_Target": 85.0}, "HOLX": {"Ticker": "HOLX", "Company": "Hologic", "Sector": "Health Care", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$75"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$75"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "Mizuho"], "Price_Target": 75.0}, "ILMN": {"Ticker": "ILMN", "Company": "Illumina", "Sector": "Health Care", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$282"}, {"Date": "2022-10-04", "Rating": "Upgrade", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$220 to $270"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$170 to $250"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["SVB Leerink", "RBC Capital Mkts", "Evercore ISI"], "Price_Target": 267.33}, "MTB": {"Ticker": "MTB", "Company": "M&T Bank", "Sector": "Financials", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$215 to $180"}, {"Date": "2022-12-05", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$220 to $235"}, {"Date": "2022-10-04", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$200"}, {"Date": "2022-09-28", "Rating": "Resumed", "Organization": "Wedbush", "Rating_Change": "Neutral", "Target_Change": "$187"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Keefe Bruyette", "Morgan Stanley", "Wedbush"], "Price_Target": 200.5}, "NRG": {"Ticker": "NRG", "Company": "NRG Energy", "Sector": "Utilities", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Neutral to Sell", "Target_Change": "$42 to $30"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["UBS"], "Price_Target": 30.0}, "RSG": {"Ticker": "RSG", "Company": "Republic Services", "Sector": "Industrials", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$152 to $148"}, {"Date": "2022-10-25", "Rating": "Resumed", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$165"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["BMO Capital Markets", "Jefferies"], "Price_Target": 156.5}, "TMO": {"Ticker": "TMO", "Company": "Thermo Fisher Scientific", "Sector": "Health Care", "Updated": "2022-12-07", "Rating": [{"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$661"}, {"Date": "2022-10-27", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Buy to Hold", "Target_Change": ""}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "The Benchmark Company"], "Price_Target": 661.0}}